TotalMarketCap

Altimmune

ALTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$382.227 M

$1.97 -7.31%

Close of 6 Nov 2026

As of 6 Nov 2026, Altimmune (ALT) has a market capitalization of $382.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$41.0K

#3588 by revenue

Earnings

-$88.1M

Loss-making

Shares outstanding

194,517,701

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #207KamadaKMDA$397.0M
  2. #208BlossomHill TherapeuticsBLSM$385.2M
  3. #209AltimmuneALT$382.2M
  4. #210Lyell ImmunopharmaLYEL$360.9M
  5. #211Avalo TherapeuticsAVTX$355.6M

What if Altimmune were worth as much as…

Open the what-if tool →

Gold $28.2T

$145,163.52

Per share 73,875× higher

Bitcoin $1.53T

$7,854.55

Per share 3,997× higher

Apple $5.02T

$25,785.74

Per share 13,123× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Altimmune are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.